Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Diagnostic HER2DX-guided Treatment for patIents wIth Early-stage HER2-positive Breast Cancer

NCT06446882 is registered in ClinicalTrials.gov with Fundacio Clinic Barcelona as lead sponsor.

NCT NCT06446882
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06446882 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Diagnostic HER2DX-guided Treatment for patIents wIth Early-stage HER2-positive Breast Cancer
Lead sponsor
Fundacio Clinic Barcelona
Phase
Not applicable
Overall status
Recruiting
Start date
October 11, 2024
Completion date
November 30, 2028
Enrollment
304 (estimated)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

early-stage breast cancer, her2-positive breast cancer